Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

ADVANCED MEDICAL TECHNOLOGY ASSN

Filed by ADVANCED MEDICAL TECHNOLOGY ASSN.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
Not reported
Expenses
$942,000.00
Filing UUID
b08c7ecb-f9c3-4d89-9c28-0cd157137b58
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule

Literal federal measure citations: S. 1399, S. 1717, H.R. 5343, S. 2761, H.R. 5269

HCR · Health Issues

Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838 Issues related to FDA regulation of diagnostic tests.

Literal federal measure citations: HR 1539, S. 2296, H.R. 3838

BUD · Budget/Appropriations

Issues related to appropriations and user fee funding for the Food and Drug Administration

TAX · Taxation/Internal Revenue Code

Issues related to R&D Expense Amortization Issues related to small business taxes Issues related to capital investment expensing Issues related to Qualified Small Business Stock

TRD · Trade (domestic/foreign)

Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs Japan Reimbursement

SMB · Small Business

Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes. Issues related to Qualified Small Business Stock.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.